Setback: Johnson and Johnson halts Covid vaccine trial over unexplained illness in participant Ruchika Sharma13 Oct 2020 1:02 PM ISTThe participant's illness is being reviewed and evaluated by an independent data and safety monitoring board as well as the company's clinical and...
COVID Vaccine trial at PGIMER: No adverse effects reported in 53 volunteers after first dose Medical Dialogues Bureau10 Oct 2020 9:30 AM IST"Very few people developed fever or body ache post vaccine administration. It is expected and very normal after the vaccine dose is given. Nothing to...
Union Health Minister unveils Web Portal For COVID-19 Vaccine Medical Dialogues Bureau29 Sept 2020 9:15 AM ISTDr harsh Vardhan said, "The portal provides useful and important information related to vaccine development, ongoing clinical trials, and progress...
Pharma giants to inform risk of COVID vaccine-associated Enhanced Respiratory Disease: DCGI Ruchika Sharma25 Sept 2020 1:46 PM ISTDr Bhargava answered in view of the draft guidelines published by the Central Drugs Standard Control Organisation (CDSCO) for the development of a...
CDSCO plans to approve Covid-19 vaccines showing 50 percent efficacy in clinical trial Farhat Nasim22 Sept 2020 6:51 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines that plan to approve COVID-19 vaccines that...
Union Minister Gowda lauds contribution of Indian pharma industry amid COVID-19 crisis Ruchika Sharma20 Sept 2020 11:30 AM ISTUnion Minister also stressed that the Indian pharma and medical devices industry was able to rise to the occasion.
COVID Vaccine Sputnik V: Significant movement on Russian request for phase-3 trial in India Farhat Nasim11 Sept 2020 9:00 AM IST“We are paving was for such a phase-3 trial or bridging studies, as per requirements of the regulatory system, to be facilitated by the government of...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
Bharat Biotech Covid-19 vaccine phase-2 trial to begin in PGI Rohtak Medical Dialogues Bureau10 Sept 2020 10:15 AM IST"In India, Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR is in the Phase II trial along with Zydus Cadila's candidate...
Russian COVID vaccine Sputnik V induces antibody response in small human trials Medical Dialogues Bureau5 Sept 2020 11:36 AM ISTThese vaccines aim to stimulate both arms of the immune system -- antibody and T cell responses -- so they attack the virus when it is circulating in...
Bharat Biotech, Zydus Cadila COVID-19 vaccine in phase 2 trial, says VK Paul Medical Dialogues Bureau1 Sept 2020 10:15 AM ISTNew Delhi: Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two...
French drugmaker Sanofi more confident about its COVID vaccines: Report Farhat Nasim31 Aug 2020 9:45 AM IST“Our confidence has increased. We have work to do like everybody on manufacturing in large volumes. But we will have one, maybe two vaccines next...
